Form 8-K CANCER GENETICS, INC For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cancer Genetics (CGIX) Misses Q3 EPS by 7c
November 10, 2015 8:14 AM ESTCancer Genetics (NASDAQ: CGIX) reported Q3 EPS of ($0.56), $0.07 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $4 million versus the consensus estimate of $5.13 million.
For earnings history and earnings-related data on Cancer Genetics (CGIX) click here.
... More